Extravasation is the leakage of a damaging medication or fluid out of a vein and into the surrounding tissue during an IV infusion. Unlike ordinary IV leaks, extravasation specifically involves substances that can injure tissue, sometimes severely enough to cause blistering, skin breakdown, or deep tissue death. It’s relatively rare, occurring in roughly 0.001% of infusions involving high-risk drugs, but when it happens, quick action determines whether the outcome is minor irritation or lasting damage.
Extravasation vs. Infiltration
The two terms are often confused because both involve fluid escaping from a vein into nearby tissue. The difference comes down to what leaks out. Infiltration refers to the leakage of a non-damaging fluid, like saline or certain mild medications. It typically causes temporary swelling and discomfort that resolves on its own once the IV is stopped.
Extravasation is more serious because the escaped substance is a “vesicant,” a drug or solution capable of causing chemical injury to tissue. Vesicants can destroy cells on contact, leading to inflammation, blistering, and in severe cases, tissue that dies and sloughs away. Both complications can happen through peripheral IVs (the kind placed in your hand or forearm) or central lines, though the consequences of extravasation are far more significant and require immediate intervention.
Which Drugs Cause the Most Damage
Not every IV medication poses this risk. The drugs most likely to cause tissue injury fall into a few categories:
- Chemotherapy agents: These are the most well-known culprits. Anthracyclines (used in many breast and blood cancers), vinca alkaloids (used in lymphomas and leukemias), and taxanes are all classified as vesicants. Docetaxel, a taxane, is the most common chemotherapy drug involved in extravasation events.
- Vasopressors: Drugs like dopamine, used to raise dangerously low blood pressure in critical care, cause tissue damage by severely constricting blood vessels. If they leak into tissue, they can cut off local blood flow.
- High-concentration solutions: Calcium chloride, calcium gluconate, and other highly concentrated fluids damage tissue through their extreme osmolarity, essentially pulling water out of cells and destroying them.
- Contrast agents: Dyes injected during CT scans and other imaging studies can also extravasate, occasionally causing significant swelling and, in rare cases, compartment syndrome.
What It Looks and Feels Like
Pain is usually the first sign. You might feel burning, stinging, or a sudden change in sensation at the IV site. Other early signs include redness, swelling, and tenderness around the area where the needle or catheter sits. At this stage, the skin still looks relatively normal.
As the injury progresses, more alarming signs appear: the skin may blister, become mottled or darkened, or feel unusually firm to the touch. In the most severe cases, the skin turns white and doesn’t change color when pressed, a sign that the full thickness of skin has been damaged. Ulceration, where the tissue breaks down into an open wound, typically doesn’t become visible until one to two weeks after the initial event, which is why ongoing monitoring matters even if the site initially looks mild.
Clinicians use a four-stage grading system to assess severity. Stages 1 and 2 involve pain, swelling, and redness but no visible skin loss. Stages 3 and 4 involve extensive soft tissue damage, including skin death and deeper tissue destruction that may require surgical treatment.
What Happens When It’s Detected
The immediate response follows a consistent sequence. The infusion is stopped right away, but the IV line is left in place briefly so that medical staff can attempt to withdraw as much of the leaked drug as possible using a syringe. After aspiration, the tubing is disconnected and further steps depend on the specific drug involved.
Cold vs. Warm Compresses
One of the most important decisions is whether to apply cold or warmth to the site, and the answer depends on the drug. Cold compresses are used for most vesicant chemotherapy agents. Cold narrows blood vessels and slows the spread of the drug, keeping it contained so the body can reabsorb it locally. Warm compresses do the opposite: they encourage the drug to disperse into a wider area, diluting its concentration so it causes less damage in any one spot.
Warm compresses are specifically recommended for vinca alkaloids, etoposide, and oxaliplatin, as well as for vasopressors (where cold would worsen the blood vessel constriction already causing the problem), solutions with extreme pH levels, and highly concentrated fluids. When it’s unclear which approach is best, the choice may come down to patient comfort combined with other treatments. Compresses are applied for 15 to 20 minutes at a time, repeated several times a day for 24 to 48 hours.
Antidotes
Certain extravasations have specific antidotes that can be administered through the existing IV line or injected directly around the affected area. For anthracycline chemotherapy drugs, a protective agent can be given intravenously to neutralize the drug in tissue. For vasopressor extravasation, a medication that reverses blood vessel constriction is injected locally around the site. For high-concentration and high-osmolarity solutions, an enzyme that breaks down the barrier between cells can be used to help the leaked fluid spread and absorb more quickly, reducing the concentration of damage in one spot.
Potential Long-Term Complications
Most extravasation injuries, when caught early and treated promptly, heal without permanent consequences. But severe or delayed cases can lead to significant problems. Tissue necrosis, where skin and deeper tissue die, sometimes requires surgical removal of the dead tissue (debridement) or skin grafting to repair the wound. Nerve damage at the site can cause lasting numbness or tingling. Scarring may limit future IV access in that area.
In rare but serious cases, the volume of leaked fluid can build up enough pressure in a confined space of the arm or hand to cause compartment syndrome. The warning signs are severe: pain that seems far worse than the injury should cause, pale or cool fingers, numbness, and inability to move the affected hand or fingers. This is a surgical emergency. Even with successful treatment, one published case documented moderate disability in the affected hand 15 months later, including weakness, reduced sensation in the fingers, and persistent functional limitations.
How Extravasation Is Prevented
Prevention starts with where and how the IV is placed. Certain locations on the body carry higher risk. Joints are avoided because they’re difficult to secure and, if a vesicant leaks, nearby nerves and tendons are vulnerable. The inner elbow (antecubital fossa) is also a poor choice because extravasation there is extremely difficult to detect early due to the depth of tissue.
During infusion of high-risk drugs, monitoring is more intensive than with routine IVs. Staff check for blood return in the line before and during administration, which confirms the catheter tip is still properly seated inside the vein. Flushing the line with saline between medications helps verify that the pathway is clear. The site is watched for any swelling, redness, or firmness.
Your own awareness plays a role too. If you’re receiving chemotherapy or another vesicant drug through an IV, you should know what to watch for. Any new burning, stinging, or change in sensation at the IV site is worth reporting immediately, even if it seems minor. Pain is the earliest and most reliable warning sign, and catching an extravasation in the first moments makes every subsequent treatment more effective.